HMGB1 is an early mediator of inflammation and may be negatively regulated by soluble receptor for advanced glycation end products in experimental endotoxinemia and in sepsis

Podobne knjige/članki

• Elevated plasma levels of heparin-binding protein in intensive care unit patients with severe sepsis and septic shock
  od: Linder, Adam, et al.
  Izdano: (2012)
• Short- and Long-Term Mortality in Severe Sepsis/Septic Shock in a Setting with Low Antibiotic Resistance: A Prospective Observational Study in a Swedish University Hospital
  od: Linnér, Anna, et al.
  Izdano: (2013)
• Soluble B and T Lymphocyte Attenuator Correlates to Disease Severity in Sepsis and High Levels Are Associated with an Increased Risk of Mortality
  od: Lange, Anna, et al.
  Izdano: (2017)
• Resistin in severe bacterial infections
  od: Johansson, Linda, et al.
  Izdano: (2007)
• Chronic Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers Is High Among Intensive Care Unit Patients With Non–COVID-19 Sepsis but Carries a Moderately Increased Risk of Death
  od: Sunden-Cullberg, Jonas
  Izdano: (2020)